Interleukin-6, its role in fibrosing conditions
- 30 June 2012
- journal article
- review article
- Published by Elsevier BV in Cytokine & Growth Factor Reviews
- Vol. 23 (3), 99-107
- https://doi.org/10.1016/j.cytogfr.2012.04.003
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Interleukin 6 Underlies Angiotensin II–Induced Hypertension and Chronic Renal DamageHypertension, 2012
- Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat HeartJournal of Biological Chemistry, 2012
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signalingJCI Insight, 2011
- IL‐6 promotes acute and chronic inflammatory disease in the absence of SOCS3Immunology & Cell Biology, 2011
- Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor SheddingJournal of Biological Chemistry, 2011
- Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow TransplantationClinical Cancer Research, 2011
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumabRheumatology, 2010
- Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in RatsHypertension, 2010
- Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host diseaseBlood, 2009
- IL-6 Modulates Alpha-Smooth Muscle Actin Expression in Dermal Fibroblasts from IL-6-Deficient MiceJournal of Investigative Dermatology, 2006